Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xyprovit
- Development stage
- Unknown
- Lead developer
- Troikaa Parenterals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xyprovit (marketed as Xyprovit Lozenges) is an approved, finished commercial drug product developed by Troikaa Parenterals. It is formulated as a lozenge for oral administration. As a finished branded generic product, it does not have active clinical development phases or specified molecular targets in pipeline registries.
- Brand names
- XyprovitXyprovit Lozenges
Beyond the preview
Go deeper on Xyprovit.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xyprovit.